BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Häussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology. 2002;35:357-366. [PMID: 11826409 DOI: 10.1053/jhep.2002.30957] [Cited by in Crossref: 279] [Cited by in F6Publishing: 234] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Kruczek C, Görg B, Keitel V, Bidmon HJ, Schliess F, Häussinger D. Ammonia increases nitric oxide, free Zn(2+), and metallothionein mRNA expression in cultured rat astrocytes. Biol Chem 2011;392:1155-65. [PMID: 22050230 DOI: 10.1515/BC.2011.199] [Reference Citation Analysis]
2 Prakash RK, Kanna S, Mullen KD. Evolving Concepts: The Negative Effect of Minimal Hepatic Encephalopathy and Role for Prophylaxis in Patients With Cirrhosis. Clinical Therapeutics 2013;35:1458-73. [DOI: 10.1016/j.clinthera.2013.07.421] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
3 Kircheis G, Fleig WE, Görtelmeyer R, Grafe S, Häussinger D. Assessment of low-grade hepatic encephalopathy: a critical analysis. J Hepatol 2007;47:642-50. [PMID: 17869373 DOI: 10.1016/j.jhep.2007.05.019] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
4 Dhiman RK, Kurmi R, Thumburu KK, Venkataramarao SH, Agarwal R, Duseja A, Chawla Y. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci. 2010;55:2381-2390. [PMID: 20508990 DOI: 10.1007/s10620-010-1249-7] [Cited by in Crossref: 128] [Cited by in F6Publishing: 119] [Article Influence: 10.7] [Reference Citation Analysis]
5 Greinert R, Zipprich A, Simón-Talero M, Stangl F, Ludwig C, Wienke A, Praktiknjo M, Höhne K, Trebicka J, Genescà J, Ripoll C. Covert hepatic encephalopathy and spontaneous portosystemic shunts increase the risk of developing overt hepatic encephalopathy. Liver Int 2020;40:3093-102. [PMID: 32890428 DOI: 10.1111/liv.14660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Butterworth RF. Hepatic Encephalopathy. In: Arias IM, Alter HJ, Boyer JL, Cohen DE, Shafritz DA, Thorgeirsson SS, Wolkoff AW, editors. The Liver. Wiley; 2020. pp. 615-29. [DOI: 10.1002/9781119436812.ch48] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Berlioux P, Robic MA, Poirson H, Métivier S, Otal P, Barret C, Lopez F, Péron JM, Vinel JP, Bureau C. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests. Hepatology 2014;59:622-9. [PMID: 24620380 DOI: 10.1002/hep.26684] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
8 Labenz C, Toenges G, Schattenberg JM, Nagel M, Huber Y, Marquardt JU, Labenz J, Galle PR, Wörns MA. Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies. Clin Transl Gastroenterol 2020;11:e00172. [PMID: 32568474 DOI: 10.14309/ctg.0000000000000172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zafiris O, Kircheis G, Rood HA, Boers F, Häussinger D, Zilles K. Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study.Neuroimage. 2004;22:541-552. [PMID: 15193582 DOI: 10.1016/j.neuroimage.2004.01.038] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 3.8] [Reference Citation Analysis]
10 Häussinger D, Córdoba J, Kircheis G, Vilstrup H, Fleig WE, Jones EA, Schleiss F, Blei AT. Definition and assessment of low-grade hepatic encephalopathy. In: Häussinger D, Kircheis G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. Dordrecht: Springer Netherlands; 2006. pp. 423-32. [DOI: 10.1007/1-4020-4456-9_32] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
11 Kircheis G, Häussinger D. Management of hepatic encephalopathy. J Gastroenterol Hepatol. 2002;17 Suppl 3:S260-S267. [PMID: 12472947 DOI: 10.1046/j.1440-1746.17.s3.11.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
12 Waghray N, Waghray A, Mullen K. Treatment options for covert hepatic encephalopathy. Curr Treat Options Gastroenterol. 2014;12:229-241. [PMID: 24623592 DOI: 10.1007/s11938-014-0014-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Lunia MK, Sharma BC, Sachdeva S. Small intestinal bacterial overgrowth and delayed orocecal transit time in patients with cirrhosis and low-grade hepatic encephalopathy. Hepatol Int. 2013;7:268-273. [PMID: 26201641 DOI: 10.1007/s12072-012-9360-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
14 Mayer LB, Krawczyk M, Grünhage F, Lammert F, Stokes CS. A genetic variant in the promoter of phosphate-activated glutaminase is associated with hepatic encephalopathy. J Intern Med 2015;278:313-22. [DOI: 10.1111/joim.12374] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
15 Sharma P, Kumar A, Singh S, Tyagi P, Kumar A. Inhibitory control test, critical flicker frequency, and psychometric tests in the diagnosis of minimal hepatic encephalopathy in cirrhosis. Saudi J Gastroenterol. 2013;19:40-44. [PMID: 23319037 DOI: 10.4103/1319-3767.105924] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
16 Amodio P. Current Diagnosis and Classification of Hepatic Encephalopathy. J Clin Exp Hepatol 2018;8:432-7. [PMID: 30564001 DOI: 10.1016/j.jceh.2018.07.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
17 Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, Wong P. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60:715-735. [PMID: 25042402 DOI: 10.1002/hep.27210] [Cited by in Crossref: 879] [Cited by in F6Publishing: 680] [Article Influence: 109.9] [Reference Citation Analysis]
18 Montoliu C, Gonzalez-Escamilla G, Atienza M, Urios A, Gonzalez O, Wassel A, Aliaga R, Giner-Duran R, Serra MA, Rodrigo JM. Focal cortical damage parallels cognitive impairment in minimal hepatic encephalopathy. Neuroimage. 2012;61:1165-1175. [PMID: 22465844 DOI: 10.1016/j.neuroimage.2012.03.041] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
19 Huda A, Gupta RK, Rajakumar N, Thomas MA. Role of Magnetic Resonance in Understanding the Pathogenesis of Hepatic Encephalopathy. Magn Reson Insights 2008;2:109-22. [PMID: 20890387 DOI: 10.4137/mri.s973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
20 Sharma P, Sharma BC. Predictors of minimal hepatic encephalopathy in patients with cirrhosis. Saudi J Gastroenterol. 2010;16:181-187. [PMID: 20616413 DOI: 10.4103/1319-3767.65189] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
21 Ridola L, Faccioli J, Nardelli S, Gioia S, Riggio O. Hepatic Encephalopathy: Diagnosis and Management. J Transl Int Med 2020;8:210-9. [PMID: 33511048 DOI: 10.2478/jtim-2020-0034] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Felipo V. Hepatic encephalopathy: effects of liver failure on brain function. Nat Rev Neurosci. 2013;14:851-858. [PMID: 24149188 DOI: 10.1038/nrn3587] [Cited by in Crossref: 196] [Cited by in F6Publishing: 186] [Article Influence: 21.8] [Reference Citation Analysis]
23 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications. Clin Mol Hepatol 2020;26:83-127. [PMID: 31918536 DOI: 10.3350/cmh.2019.0010n] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
24 Atluri DK, Prakash R, Mullen KD. Pathogenesis, diagnosis, and treatment of hepatic encephalopathy. J Clin Exp Hepatol. 2011;1:77-86. [PMID: 25755319 DOI: 10.1016/s0973-6883(11)60126-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
25 Heiser C, Haller B, Sohn M, Hofauer B, Knopf A, Mühling T, Freiherr J, Bender M, Tiller M, Schmidt A, Schepp W, Gundling F. Olfactory Function is Affected in Patients with Cirrhosis Depending on the Severity of Hepatic Encephalopathy. Annals of Hepatology 2018;17:822-9. [DOI: 10.5604/01.3001.0012.3143] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
26 Grover VB, Dresner MA, Forton DM, Counsell S, Larkman DJ, Patel N, Thomas HC, Taylor-Robinson SD. Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy. World J Gastroenterol 2006; 12(19): 2969-2978 [PMID: 16718775 DOI: 10.3748/wjg.v12.i19.2969] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
27 Sharma P, Sharma BC, Sarin SK. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis. Liver Int. 2009;29:1365-1371. [PMID: 19555401 DOI: 10.1111/j.1478-3231.2009.02067.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
28 Francisco Rivera Ramos J, Rodríguez Leal C. Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy. Annals of Hepatology 2011;10:S36-9. [DOI: 10.1016/s1665-2681(19)31604-7] [Cited by in Crossref: 11] [Article Influence: 1.0] [Reference Citation Analysis]
29 Bajaj JS. Hepatic encephalopathy: classification and treatment. J Hepatol 2018;68:838-9. [PMID: 29756596 DOI: 10.1016/j.jhep.2017.11.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
30 Maier M, Brückmann A, Schleußner E, Schlembach D. Using critical flicker frequency in the evaluation of visual impairment in preeclamptic women. Eur J Obstet Gynecol Reprod Biol 2017;211:188-93. [PMID: 28292692 DOI: 10.1016/j.ejogrb.2017.02.029] [Reference Citation Analysis]
31 Butz M, Timmermann L, Braun M, Groiss SJ, Wojtecki L, Ostrowski S, Krause H, Pollok B, Gross J, Südmeyer M. Motor impairment in liver cirrhosis without and with minimal hepatic encephalopathy. Acta Neurol Scand. 2010;122:27-35. [PMID: 20003084 DOI: 10.1111/j.1600-0404.2009.01246.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
32 Butz M, May ES, Häussinger D, Schnitzler A. The slowed brain: Cortical oscillatory activity in hepatic encephalopathy. Archives of Biochemistry and Biophysics 2013;536:197-203. [DOI: 10.1016/j.abb.2013.04.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
33 Dhiman RK, Chawla YK. Minimal hepatic encephalopathy. Indian J Gastroenterol. 2009;28:5-16. [PMID: 19529896 DOI: 10.1007/s12664-009-0003-6] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
34 Montgomery JY, Bajaj JS. Advances in the evaluation and management of minimal hepatic encephalopathy. Curr Gastroenterol Rep. 2011;13:26-33. [PMID: 20924726 DOI: 10.1007/s11894-010-0150-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
35 Yadav SK, Srivastava A, Srivastava A, Thomas MA, Agarwal J, Pandey CM, Lal R, Yachha SK, Saraswat VA, Gupta RK. Encephalopathy assessment in children with extra-hepatic portal vein obstruction with MR, psychometry and critical flicker frequency. J Hepatol 2010;52:348-54. [PMID: 20137823 DOI: 10.1016/j.jhep.2009.12.012] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
36 Goh ET, Andersen ML, Morgan MY, Gluud LL. Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy. Cochrane Database Syst Rev 2017;7:CD002798. [PMID: 28745801 DOI: 10.1002/14651858.CD002798.pub3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
37 Wunsch E, Naprawa G, Koziarska D, Milkiewicz M, Nowacki P, Milkiewicz P. Serum natremia affects health-related quality of life in patients with liver cirrhosis: a prospective, single centre study. Annals of Hepatology 2013;12:448-55. [DOI: 10.1016/s1665-2681(19)31008-7] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
38 Ferenci P, Müller C. Hepatic Encephalopathy: Treatment. In: Mcdonald JW, Burroughs AK, Feagan BG, Fennerty MB, editors. Evidence‐Based Gastroenterology and Hepatology. Wiley; 2010. pp. 636-49. [DOI: 10.1002/9781444314403.ch39] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Solinas A, Piras MR, Deplano A. Cognitive dysfunction and hepatitis C virus infection. World J Hepatol 2015; 7(7): 922-925 [PMID: 25954475 DOI: 10.4254/wjh.v7.i7.922] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
40 Sharma P, Sharma BC. Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Saudi J Gastroenterol 2012;18:168-72. [PMID: 22626795 DOI: 10.4103/1319-3767.96448] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
41 Mullen KD, Amodio P, Morgan MY. Therapeutic studies in hepatic encephalopathy. Metab Brain Dis 2007;22:407-23. [DOI: 10.1007/s11011-007-9061-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
42 Stokes CS, Goh ET, Vilstrup H, Morgan MY, Gluud LL; Cochrane Hepato-Biliary Group. L-ornithine L-aspartate for people with cirrhosis and hepatic encephalopathy. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd012410] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
43 Greinert R, Ripoll C, Hollenbach M, Zipprich A. Stepwise diagnosis in covert hepatic encephalopathy: critical flicker frequency and MELD-score as a first-step approach. Aliment Pharmacol Ther 2016;44:514-21. [PMID: 27385440 DOI: 10.1111/apt.13721] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
44 Kim YK, Song J. Therapeutic Applications of Resveratrol in Hepatic Encephalopathy through Its Regulation of the Microbiota, Brain Edema, and Inflammation. J Clin Med 2021;10:3819. [PMID: 34501267 DOI: 10.3390/jcm10173819] [Reference Citation Analysis]
45 Zacharias HD, Zacharias AP, Gluud LL, Morgan MY. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis. Cochrane Database Syst Rev 2019;6:CD012334. [PMID: 31204790 DOI: 10.1002/14651858.CD012334.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
46 Eisen-Enosh A, Farah N, Burgansky-Eliash Z, Polat U, Mandel Y. Evaluation of Critical Flicker-Fusion Frequency Measurement Methods for the Investigation of Visual Temporal Resolution. Sci Rep 2017;7:15621. [PMID: 29142231 DOI: 10.1038/s41598-017-15034-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
47 Guzel A, Gunbey E, Koksal N. The performance of critical flicker frequency on determining of neurocognitive function loss in severe obstructive sleep apnea syndrome. J Sleep Res 2017;26:651-6. [PMID: 28382650 DOI: 10.1111/jsr.12531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
48 Mallick T, Kulkarni R. The Effect of Trataka , a Yogic Visual Concentration Practice, on Critical Flicker Fusion. The Journal of Alternative and Complementary Medicine 2010;16:1265-7. [DOI: 10.1089/acm.2010.0012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
49 Sharma P, Sharma BC, Puri V, Sarin SK. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol. 2007;47:67-73. [PMID: 17459511 DOI: 10.1016/j.jhep.2007.02.022] [Cited by in Crossref: 123] [Cited by in F6Publishing: 106] [Article Influence: 8.2] [Reference Citation Analysis]
50 Gluud LL, Vilstrup H, Morgan MY. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database Syst Rev. 2016;CD003044. [PMID: 27153247 DOI: 10.1002/14651858.cd003044.pub4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
51 Felipo V, Urios A, Valero P, Sánchez M, Serra MA, Pareja I, Rodríguez F, Gimenez-Garzó C, Sanmartín J, Montoliu C. Serum nitrotyrosine and psychometric tests as indicators of impaired fitness to drive in cirrhotic patients with minimal hepatic encephalopathy. Liver Int. 2013;33:1478-1489. [PMID: 23714168 DOI: 10.1111/liv.12206] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
52 Ridola L, Cardinale V, Riggio O. The burden of minimal hepatic encephalopathy: From diagnosis to therapeutic strategies. Ann Gastroenterol. 2018;31:151-164. [PMID: 29507462 DOI: 10.20524/aog.2018.0232] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
53 Baumgarten TJ, Neugebauer J, Oeltzschner G, Füllenbach ND, Kircheis G, Häussinger D, Lange J, Wittsack HJ, Butz M, Schnitzler A. Connecting occipital alpha band peak frequency, visual temporal resolution, and occipital GABA levels in healthy participants and hepatic encephalopathy patients. Neuroimage Clin 2018;20:347-56. [PMID: 30109194 DOI: 10.1016/j.nicl.2018.08.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
54 Lazar M, Butz M, Baumgarten TJ, Füllenbach ND, Jördens MS, Häussinger D, Schnitzler A, Lange J. Impaired Tactile Temporal Discrimination in Patients With Hepatic Encephalopathy. Front Psychol 2018;9:2059. [PMID: 30425672 DOI: 10.3389/fpsyg.2018.02059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
55 Romero-Gómez M, Córdoba J, Jover R, del Olmo JA, Ramírez M, Rey R, de Madaria E, Montoliu C, Nuñez D, Flavia M, Compañy L, Rodrigo JM, Felipo V. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007;45:879-85. [PMID: 17393525 DOI: 10.1002/hep.21586] [Cited by in Crossref: 212] [Cited by in F6Publishing: 183] [Article Influence: 14.1] [Reference Citation Analysis]
56 Savlan I, Liakina V, Valantinas J. Concise review of current concepts on nomenclature and pathophysiology of hepatic encephalopathy. Medicina (Kaunas). 2014;50:75-81. [PMID: 25172600 DOI: 10.1016/j.medici.2014.06.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
57 Gundling F, Schmidtler F, Hapfelmeier A, Schulte B, Schmidt T, Pehl C, Schepp W, Seidl H. Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis. Liver Int. 2011;31:1406-1415. [PMID: 22093455 DOI: 10.1111/j.1478-3231.2011.02577.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
58 Bjerring PN, Morgan MY, Vilstrup H, Nielsen SM, Christensen R, Gluud LL; Cochrane Hepato-Biliary Group. Medical interventions for prevention and treatment of hepatic encephalopathy in adults with cirrhosis: a network meta-analysis. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd013241] [Reference Citation Analysis]
59 Bajaj JS, Wade JB, Sanyal AJ. Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy. Hepatology. 2009;50:2014-2021. [PMID: 19787808 DOI: 10.1002/hep.23216] [Cited by in Crossref: 223] [Cited by in F6Publishing: 198] [Article Influence: 17.2] [Reference Citation Analysis]
60 Bajaj JS. Review article: the modern management of hepatic encephalopathy. Aliment Pharmacol Ther. 2010;31:537-547. [PMID: 20002027 DOI: 10.1111/j.1365-2036.2009.04211.x] [Cited by in Crossref: 163] [Cited by in F6Publishing: 127] [Article Influence: 12.5] [Reference Citation Analysis]
61 Shah NM, Malhotra AM, Kaltsakas G. Sleep disorder in patients with chronic liver disease: a narrative review. J Thorac Dis 2020;12:S248-60. [PMID: 33214928 DOI: 10.21037/jtd-cus-2020-012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
62 Shah NJ, Neeb H, Kircheis G, Engels P, Häussinger D, Zilles K. Quantitative cerebral water content mapping in hepatic encephalopathy. Neuroimage 2008;41:706-17. [PMID: 18456518 DOI: 10.1016/j.neuroimage.2008.02.057] [Cited by in Crossref: 101] [Cited by in F6Publishing: 89] [Article Influence: 7.2] [Reference Citation Analysis]
63 Romero-Gómez M. Critical flicker frequency: it is time to break down barriers surrounding minimal hepatic encephalopathy. J Hepatol. 2007;47:10-11. [PMID: 17507110 DOI: 10.1016/j.jhep.2007.04.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
64 Shawcross DL, Dunk AA, Jalan R, Kircheis G, de Knegt RJ, Laleman W, Ramage JK, Wedemeyer H, Morgan IE; New Insights Steering Committee. How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and responsibilities beyond the liver specialist. Eur J Gastroenterol Hepatol. 2016;28:146-152. [PMID: 26600154 DOI: 10.1097/meg.0000000000000529] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
65 Ampuero J, Montoliú C, Simón-Talero M, Aguilera V, Millán R, Márquez C, Jover R, Rico MC, Sendra C, Serra MÁ, Romero-Gómez M. Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression. J Gastroenterol Hepatol 2018;33:718-25. [PMID: 28768371 DOI: 10.1111/jgh.13917] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
66 Kappus MR, Bajaj JS. Covert hepatic encephalopathy: Not as minimal as you might think. Clin Gastroenterol Hepatol. 2012;10:1208-1219. [PMID: 22728384 DOI: 10.1016/j.cgh.2012.05.026] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 5.5] [Reference Citation Analysis]
67 Zhan T, Stremmel W. The diagnosis and treatment of minimal hepatic encephalopathy. Dtsch Arztebl Int. 2012;109:180-187. [PMID: 22470407 DOI: 10.3238/arztebl.2012.0180] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
68 Kornerup LS, Pflugrad H, Weissenborn K, Vilstrup H, Dam G. Cognitive impairment after liver transplantation: residual hepatic encephalopathy or posttransplant encephalopathy? Hepat Med 2019;11:41-6. [PMID: 31040728 DOI: 10.2147/HMER.S144667] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
69 Montagnese S, Middleton B, Corrias M, Mani AR, Skene DJ, Morgan MY. Assessment of 6-sulfatoxymelatonin rhythms and melatonin response to light in disease states: lessons from cirrhosis. Chronobiol Int 2015;32:187-94. [PMID: 25264562 DOI: 10.3109/07420528.2014.961607] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
70 Felipo V, Urios A, Giménez-Garzó C, Cauli O, Andrés-Costa MJ, González O, Serra MA, Sánchez-González J, Aliaga R, Giner-Durán R, Belloch V, Montoliu C. Non invasive blood flow measurement in cerebellum detects minimal hepatic encephalopathy earlier than psychometric tests. World J Gastroenterol 2014; 20(33): 11815-11825 [PMID: 25206287 DOI: 10.3748/wjg.v20.i33.11815] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
71 Lunia MK, Sharma BC, Sharma P, Sachdeva S, Srivastava S. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial. Clin Gastroenterol Hepatol 2014; 12: 1003-8. e1. [PMID: 24246768 DOI: 10.1016/j.cgh.2013.11.006] [Cited by in Crossref: 96] [Cited by in F6Publishing: 88] [Article Influence: 10.7] [Reference Citation Analysis]
72 Labenz C, Baron JS, Toenges G, Schattenberg JM, Nagel M, Sprinzl MF, Nguyen-Tat M, Zimmermann T, Huber Y, Marquardt JU. Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients. Aliment Pharmacol Ther. 2018;48:313-321. [PMID: 29863286 DOI: 10.1111/apt.14824] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
73 Nakanishi H, Kurosaki M, Nakanishi K, Tsuchiya K, Noda T, Tamaki N, Yasui Y, Hosokawa T, Ueda K, Itakura J, Anami K, Asahina Y, Enomoto N, Higuchi T, Izumi N. Impaired brain activity in cirrhotic patients with minimal hepatic encephalopathy: Evaluation by near-infrared spectroscopy. Hepatol Res 2014;44:319-26. [PMID: 23607661 DOI: 10.1111/hepr.12127] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
74 Neeb H, Dierkes T, Shah N. Quantitative T1 mapping and absolute water content measurement using MRI. International Congress Series 2004;1265:113-23. [DOI: 10.1016/j.ics.2004.02.168] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
75 Stokes CS, Grünhage F, Baus C, Volmer DA, Wagenpfeil S, Riemenschneider M, Lammert F. Vitamin D supplementation reduces depressive symptoms in patients with chronic liver disease. Clin Nutr 2016;35:950-7. [PMID: 26212170 DOI: 10.1016/j.clnu.2015.07.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
76 Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Ferrandez A, Rodrigo JM, Felipo V. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients. J Mol Med (Berl). 2007;85:237-245. [PMID: 17216205 DOI: 10.1007/s00109-006-0149-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
77 Goh ET, Andersen ML, Morgan MY, Gluud LL. Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy. Cochrane Database Syst Rev 2017;8:CD002798. [PMID: 28796283 DOI: 10.1002/14651858.CD002798.pub4] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
78 Luo M, Mu R, Liu JF, Bai FH. Novel computerized psychometric tests as primary screening tools for the diagnosis of minimal hepatic encephalopathy. World J Clin Cases 2020; 8(16): 3377-3389 [PMID: 32913845 DOI: 10.12998/wjcc.v8.i16.3377] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
79 Hassanein T, Blei AT, Perry W, Hilsabeck R, Stange J, Larsen FS, Brown RS, Caldwell S, McGuire B, Nevens F. Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy. Am J Gastroenterol. 2009;104:1392-1400. [PMID: 19455117 DOI: 10.1038/ajg.2009.160] [Cited by in Crossref: 53] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
80 Sotil EU, Gottstein J, Ayala E, Randolph C, Blei AT. Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation. Liver Transpl. 2009;15:184-192. [PMID: 19177446 DOI: 10.1002/lt.21593] [Cited by in Crossref: 107] [Cited by in F6Publishing: 91] [Article Influence: 8.2] [Reference Citation Analysis]
81 Bajaj JS. Current and future diagnosis of hepatic encephalopathy. Metab Brain Dis. 2010;25:107-110. [PMID: 20213105 DOI: 10.1007/s11011-010-9176-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
82 Goh ET, Stokes CS, Sidhu SS, Vilstrup H, Gluud LL, Morgan MY. L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database Syst Rev. 2018;5:CD012410. [PMID: 29762873 DOI: 10.1002/14651858.cd012410.pub2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
83 Bar N, Levy S, Deutsch L, Leshno M, Rabinowich L, Younis F, Shibolet O, Katchman H. Hepatitis C related cognitive impairment: Impact of viral and host factors and response to therapy. J Viral Hepat 2021;28:870-7. [PMID: 33624351 DOI: 10.1111/jvh.13492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Strebel H, Haller B, Sohn M, Schepp W, Gundling F. Role of Brain Biomarkers S-100-Beta and Neuron-Specific Enolase for Detection and Follow-Up of Hepatic Encephalopathy in Cirrhosis before, during and after Treatment with L-Ornithine-L-Aspartate. GE Port J Gastroenterol 2020;27:391-403. [PMID: 33251288 DOI: 10.1159/000507225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Coubard OA, Ober KM, Gaumet M, Urbanski M, Amato JN, Chapron V, Weiss N, Kinugawa K, Weissenborn K, Thabut D. Standardization of the psychometric hepatic encephalopathy score in a French population. PLoS One 2021;16:e0257136. [PMID: 34506569 DOI: 10.1371/journal.pone.0257136] [Reference Citation Analysis]
86 Román E, Torrades MT, Nadal MJ, Cárdenas G, Nieto JC, Vidal S, Bascuñana H, Juárez C, Guarner C, Córdoba J, Soriano G. Randomized Pilot Study: Effects of an Exercise Programme and Leucine Supplementation in Patients with Cirrhosis. Dig Dis Sci 2014;59:1966-75. [DOI: 10.1007/s10620-014-3086-6] [Cited by in Crossref: 105] [Cited by in F6Publishing: 103] [Article Influence: 13.1] [Reference Citation Analysis]
87 Gencdal G, Gunsar F, Meral CE, Salman E, Gürsel B, Oruç N, Karasu Z, Ersoz G, Akarca US. Diurnal changes of critical flicker frequency in patients with liver cirrhosis and their relationship with sleep disturbances. Dig Liver Dis 2014;46:1111-5. [PMID: 25192605 DOI: 10.1016/j.dld.2014.08.031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
88 Montagnese S, Russo FP, Amodio P, Burra P, Gasbarrini A, Loguercio C, Marchesini G, Merli M, Ponziani FR, Riggio O, Scarpignato C. Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). Dig Liver Dis. 2019;51:190-205. [PMID: 30606696 DOI: 10.1016/j.dld.2018.11.035] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
89 Lewis M, Howdle PD. The neurology of liver failure. QJM. 2003;96:623-633. [PMID: 12925717 DOI: 10.1093/qjmed/hcg110] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
90 Butterworth RF. Etiology of cirrhosis predicts deterioration of "brain reserve" after hepatic encephalopathy or transjugular intrahepatic portosystemic shunt. Liver Transpl 2015;21:1115-6. [PMID: 26073990 DOI: 10.1002/lt.24193] [Reference Citation Analysis]
91 Olesen SS, Graversen C, Hansen TM, Blauenfeldt RA, Hansen JB, Steimle K, Drewes AM. Spectral and dynamic electroencephalogram abnormalities are correlated to psychometric test performance in hepatic encephalopathy. Scandinavian Journal of Gastroenterology 2011;46:988-96. [DOI: 10.3109/00365521.2011.579160] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
92 American Association for the Study of Liver Diseases. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol. 2014;61:642-659. [PMID: 25015420 DOI: 10.1016/j.jhep.2014.05.042] [Cited by in Crossref: 212] [Cited by in F6Publishing: 164] [Article Influence: 26.5] [Reference Citation Analysis]
93 Nguyen HH, Swain MG, Wong P, Congly SE. Canadian regulations and legal ramifications for hepatic encephalopathy: a descriptive analysis. CMAJ Open 2018;6:E575-9. [PMID: 30510040 DOI: 10.9778/cmajo.20180024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
94 Zacharias HD, Zacharias AP, Oliveira Ferreira A, Morgan MY, Gluud LL; Cochrane Hepato-Biliary Group. Ammonia scavenging agents for people with cirrhosis and hepatic encephalopathy. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd012334] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
95 Singh J, Sharma BC, Maharshi S, Puri V, Srivastava S. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy. J Gastroenterol Hepatol. 2016;31:1203-1209. [PMID: 26716736 DOI: 10.1111/jgh.13283] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
96 Miese FR, Wittsack HJ, Kircheis G, Holstein A, Mathys C, Mödder U, Cohnen M. Voxel-based analyses of magnetization transfer imaging of the brain in hepatic encephalopathy. World J Gastroenterol 2009; 15(41): 5157-5164 [PMID: 19891014 DOI: 10.3748/wjg.15.5157] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
97 Campagna F, Montagnese S, Ridola L, Senzolo M, Schiff S, De Rui M, Pasquale C, Nardelli S, Pentassuglio I, Merkel C, Angeli P, Riggio O, Amodio P. The animal naming test: An easy tool for the assessment of hepatic encephalopathy. Hepatology. 2017;66:198-208. [PMID: 28271528 DOI: 10.1002/hep.29146] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 10.6] [Reference Citation Analysis]
98 Boy C, Meyer PT, Kircheis G, Holschbach MH, Herzog H, Elmenhorst D, Kaiser HJ, Coenen HH, Haussinger D, Zilles K, Bauer A. Cerebral A1 adenosine receptors (A1AR) in liver cirrhosis. Eur J Nucl Med Mol Imaging 2008;35:589-97. [DOI: 10.1007/s00259-007-0586-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
99 Gabriel MM, Kircheis G, Hardtke S, Markwardt D, Buggisch P, Mix H, Grüngreiff K, Welzel TM, Kälsch J, Hartmann H, Gerbes AL, Karpowitz MV, Seeliger B, Wedemeyer H, Weissenborn K. Risk of recurrent hepatic encephalopathy in patients with liver cirrhosis: a German registry study. European Journal of Gastroenterology & Hepatology 2021;33:1185-93. [DOI: 10.1097/meg.0000000000001822] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
100 Ganesh G, Mahalingam S, Annamalai G, Damodharan U. Seeing is believing: a demonstration of critical fusion frequency and its multidimensional nature. Advances in Physiology Education 2017;41:315-9. [DOI: 10.1152/advan.00170.2016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
101 Córdoba J, Lucke R. Driving under the influence of minimal hepatic encephalopathy. Hepatology 2004;39:599-601. [DOI: 10.1002/hep.20120] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
102 Nikolov P, Baumgarten TJ, Hassan SS, Meissner SN, Füllenbach ND, Kircheis G, Häussinger D, Jördens MS, Butz M, Schnitzler A, Groiss SJ. Altered motor cortical plasticity in patients with hepatic encephalopathy: A paired associative stimulation study. Clin Neurophysiol 2021;132:2332-41. [PMID: 34454259 DOI: 10.1016/j.clinph.2021.07.019] [Reference Citation Analysis]
103 Al Sibae MR, McGuire BM. Current trends in the treatment of hepatic encephalopathy. Ther Clin Risk Manag. 2009;5:617-626. [PMID: 19707277 DOI: 10.2147/tcrm.s4443] [Cited by in Crossref: 8] [Cited by in F6Publishing: 19] [Article Influence: 0.6] [Reference Citation Analysis]
104 Tapper EB, Parikh ND, Waljee AK, Volk M, Carlozzi NE, Lok AS. Diagnosis of Minimal Hepatic Encephalopathy: A Systematic Review of Point-of-Care Diagnostic Tests. Am J Gastroenterol 2018;113:529-38. [PMID: 29533396 DOI: 10.1038/ajg.2018.6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
105 Peck-Radosavljevic M. Portal hypertension--old problem, new therapeutic solutions. Wien Med Wochenschr 2006;156:397-403. [PMID: 16937042 DOI: 10.1007/s10354-006-0315-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
106 Cavalade M, Papadopoulou V, Theunissen S, Balestra C. Heart rate variability and critical flicker fusion frequency changes during and after parachute jumping in experienced skydivers. Eur J Appl Physiol 2015;115:1533-45. [PMID: 25715913 DOI: 10.1007/s00421-015-3137-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
107 Salman T, Elsabaawy M, Omar M, Afify M, Elezawy H, Ghanem S, Abdelraouf O, Rewisha E, Shebl N. Evaluation of different diagnostic modalities of minimal hepatic encephalopathy in cirrhotic patients: case-control study. Clin Exp Hepatol 2021;7:312-9. [PMID: 34712834 DOI: 10.5114/ceh.2021.109292] [Reference Citation Analysis]
108 Yadav SK, Goel A, Saraswat VA, Thomas MA, Wang E, Marincola FM, Haris M, Gupta RK. Evaluation of cognitivity, proinflammatory cytokines, and brain magnetic resonance imaging in minimal hepatic encephalopathy induced by cirrhosis and extrahepatic portal vein obstruction. J Gastroenterol Hepatol. 2016;31:1986-1994. [PMID: 27119420 DOI: 10.1111/jgh.13427] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
109 McPhail MJ, Bajaj JS, Thomas HC, Taylor-Robinson SD. Pathogenesis and diagnosis of hepatic encephalopathy. Expert Rev Gastroenterol Hepatol. 2010;4:365-378. [PMID: 20528123 DOI: 10.1586/egh.10.32] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
110 Frank Y, Ashwal S. Neurologic Disorders Associated with Gastrointestinal Diseases and Nutritional Deficiencies. Swaiman's Pediatric Neurology. Elsevier; 2012. pp. 1821-66. [DOI: 10.1016/b978-1-4377-0435-8.00079-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
111 Oeltzschner G, Butz M, Baumgarten TJ, Hoogenboom N, Wittsack H, Schnitzler A. Low visual cortex GABA levels in hepatic encephalopathy: links to blood ammonia, critical flicker frequency, and brain osmolytes. Metab Brain Dis 2015;30:1429-38. [DOI: 10.1007/s11011-015-9729-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
112 Gil-Gómez A, Ampuero J, Rojas Á, Gallego-Durán R, Muñoz-Hernández R, Rico MC, Millán R, García-Lozano R, Francés R, Soriano G, Romero-Gómez M. Development and Validation of a Clinical-Genetic Risk Score to Predict Hepatic Encephalopathy in Patients With Liver Cirrhosis. Am J Gastroenterol 2021;116:1238-47. [PMID: 33852451 DOI: 10.14309/ajg.0000000000001164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Michitaka K, Hiraoka A, Kume M, Uehara T, Hidaka S, Ninomiya T, Hasebe A, Miyamoto Y, Ichiryu M, Tanihira T. Amino acid imbalance in patients with chronic liver diseases. Hepatol Res. 2010;40:393-398. [PMID: 20236360 DOI: 10.1111/j.1872-034x.2009.00614.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
114 Wunsch E, Koziarska D, Milkiewicz M, Naprawa G, Nowacki P, Hartleb M, Milkiewicz P. In patients with liver cirrhosis, proinflammatory interleukins correlate with health-related quality of life irrespective of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2013;25:1402-1407. [PMID: 24025977 DOI: 10.1097/meg.0b013e328365a447] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
115 Agarwal A, Taneja S, Chopra M, Duseja A, Dhiman RK. Animal Naming Test - a simple and accurate test for diagnosis of minimal hepatic encephalopathy and prediction of overt hepatic encephalopathy. Clin Exp Hepatol 2020;6:116-24. [PMID: 32728628 DOI: 10.5114/ceh.2019.95105] [Reference Citation Analysis]
116 Oeltzschner G, Schnitzler A, Wickrath F, Zöllner HJ, Wittsack HJ. Use of quantitative brain water imaging as concentration reference for J-edited MR spectroscopy of GABA. Magn Reson Imaging 2016;34:1057-63. [PMID: 27109486 DOI: 10.1016/j.mri.2016.04.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
117 Elsaid MI, Rustgi VK. Epidemiology of Hepatic Encephalopathy. Clinics in Liver Disease 2020;24:157-74. [DOI: 10.1016/j.cld.2020.01.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
118 Barone M, Shahini E, Iannone A, Viggiani MT, Corvace V, Principi M, Di Leo A. Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis. Digestive and Liver Disease 2018;50:496-500. [DOI: 10.1016/j.dld.2018.01.133] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
119 Grover VP, Tognarelli JM, Massie N, Crossey MM, Cook NA, Taylor-Robinson SD. The why and wherefore of hepatic encephalopathy. Int J Gen Med 2015;8:381-90. [PMID: 26719720 DOI: 10.2147/IJGM.S86854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
120 Wunsch E, Post M, Gutkowski K, Marlicz W, Szymanik B, Hartleb M, Milkiewicz P. Critical flicker frequency fails to disclose brain dysfunction in patients with primary biliary cirrhosis. Dig Liver Dis 2010;42:818-21. [PMID: 20430705 DOI: 10.1016/j.dld.2010.03.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
121 Amodio P. Hepatic encephalopathy. In: Lee SS, Moreau R, editors. Cirrhosis: A practical guide to management. Chichester: John Wiley & Sons, Ltd; 2015. pp. 105-23. [DOI: 10.1002/9781118412640.ch11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
122 Hernández-Conde M, Fernández-Carrillo C, Llop E, Perelló C, López-Gómez M, Martínez-Porras JL, Fernández-Puga N, Calleja JL. Impact of sustained viral response in the evolution of minimal hepatic encephalopathy: A prospective pilot study. Ann Hepatol 2019;18:429-33. [PMID: 31054981 DOI: 10.1016/j.aohep.2018.07.004] [Reference Citation Analysis]
123 Bajaj JS. Management options for minimal hepatic encephalopathy. Expert Rev Gastroenterol Hepatol. 2008;2:785-790. [PMID: 19090738 DOI: 10.1586/17474124.2.6.785] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
124 Labenz C, Beul L, Toenges G, Schattenberg JM, Nagel M, Sprinzl MF, Nguyen-Tat M, Zimmermann T, Huber Y, Marquardt JU, Galle PR, Wörns MA. Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathy. Eur J Intern Med 2019;60:96-100. [PMID: 30131209 DOI: 10.1016/j.ejim.2018.08.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
125 Timmermann L, Butz M, Gross J, Kircheis G, Häussinger D, Schnitzler A. Neural Synchronization in Hepatic Encephalopathy. Metab Brain Dis 2005;20:337-46. [DOI: 10.1007/s11011-005-7916-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
126 Kappus MR, Bajaj JS. Assessment of minimal hepatic encephalopathy (with emphasis on computerized psychometric tests). Clin Liver Dis. 2012;16:43-55. [PMID: 22321464 DOI: 10.1016/j.cld.2011.12.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
127 Thuluvath PJ. Toward safer sedation in patients with cirrhosis: have we done enough? Gastrointest Endosc. 2009;70:269-271. [PMID: 19631803 DOI: 10.1016/j.gie.2009.01.029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
128 Amodio P. Hepatic encephalopathy: Diagnosis and management. Liver Int. 2018;38:966-975. [PMID: 29624860 DOI: 10.1111/liv.13752] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
129 Morgan MY, Amodio P, Cook NA, Jackson CD, Kircheis G, Lauridsen MM, Montagnese S, Schiff S, Weissenborn K. Qualifying and quantifying minimal hepatic encephalopathy. Metab Brain Dis 2016;31:1217-29. [PMID: 26412229 DOI: 10.1007/s11011-015-9726-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
130 Weissenborn K. Challenges in diagnosing hepatic encephalopathy. Neurochem Res 2015;40:265-73. [PMID: 25142937 DOI: 10.1007/s11064-014-1416-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
131 Kharbanda PS, Prabhakar S. Subclinical hepatic encephalopathy: Elusive ‘gold standard’. Journal of Gastroenterology and Hepatology 2004;19:1-3. [DOI: 10.1111/j.1440-1746.2004.03290.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
132 Moratalla A, Ampuero J, Bellot P, Gallego-Durán R, Zapater P, Roger M, Figueruela B, Martínez-Moreno B, González-Navajas JM, Such J, Romero-Gómez M, Francés R. Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy. Liver Int 2017;37:212-23. [PMID: 27388776 DOI: 10.1111/liv.13200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
133 Alonso J, Córdoba J, Rovira A. Brain magnetic resonance in hepatic encephalopathy. Semin Ultrasound CT MR. 2014;35:136-152. [PMID: 24745889 DOI: 10.1053/j.sult.2013.09.008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
134 Goldbecker A, Weissenborn K, Hamidi Shahrezaei G, Afshar K, Rümke S, Barg-Hock H, Strassburg CP, Hecker H, Tryc AB. Comparison of the most favoured methods for the diagnosis of hepatic encephalopathy in liver transplantation candidates. Gut. 2013;62:1497-1504. [PMID: 23297006 DOI: 10.1136/gutjnl-2012-303262] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 6.7] [Reference Citation Analysis]
135 Schliess F, Görg B, Häussinger D. Pathogenetic interplay between osmotic and oxidative stress: the hepatic encephalopathy paradigm. Biol Chem. 2006;387:1363-1370. [PMID: 17081108 DOI: 10.1515/bc.2006.171] [Cited by in Crossref: 58] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
136 Nevah MI, Fallon MB. Hepatic Encephalopathy, Hepatorenal Syndrome, Hepatopulmonary Syndrome, and Systemic Complications of Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Elsevier; 2010. pp. 1543-1555.e6. [DOI: 10.1016/b978-1-4160-6189-2.00092-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
137 Gluud LL, Jeyaraj R, Morgan MY. Outcomes in Clinical Trials Evaluating Interventions for the Prevention and Treatment of Hepatic Encephalopathy. J Clin Exp Hepatol 2019;9:354-61. [PMID: 31360028 DOI: 10.1016/j.jceh.2019.02.004] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
138 Agrawal A, Sharma BC, Sharma P, Uppal R, Sarin SK. Randomized controlled trial for endoscopy with propofol versus midazolam on psychometric tests and critical flicker frequency in people with cirrhosis. J Gastroenterol Hepatol. 2012;27:1726-1732. [PMID: 22861074 DOI: 10.1111/j.1440-1746.2012.07231.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
139 Gluud LL, Vilstrup H, Morgan MY. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database Syst Rev. 2016;4:CD003044. [PMID: 27089005 DOI: 10.1002/14651858.cd003044.pub3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
140 Balestra C, Lafère P, Germonpré P. Persistence of critical flicker fusion frequency impairment after a 33 mfw SCUBA dive: evidence of prolonged nitrogen narcosis? Eur J Appl Physiol 2012;112:4063-8. [DOI: 10.1007/s00421-012-2391-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
141 Shah NJ, Neeb H, Zaitsev M, Steinhoff S, Kircheis G, Amunts K, Häussinger D, Zilles K. Quantitative T1 mapping of hepatic encephalopathy using magnetic resonance imaging. Hepatology 2003;38:1219-26. [PMID: 14578860 DOI: 10.1053/jhep.2003.50477] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 3.1] [Reference Citation Analysis]
142 Yazici A, Emre Yildirim A, Konduk B, Aytaç İ, Barutçu S. A novel method: can stapedial acoustic reflex have a role in the diagnosis of minimal hepatic encephalopathy? Eur J Gastroenterol Hepatol 2021;33:717-21. [PMID: 32568804 DOI: 10.1097/MEG.0000000000001781] [Reference Citation Analysis]
143 Sharma P, Sharma BC, Puri V, Sarin SK. Natural history of minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Am J Gastroenterol 2009;104:885-90. [PMID: 19293781 DOI: 10.1038/ajg.2009.84] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
144 Román E, Córdoba J, Torrens M, Torras X, Villanueva C, Vargas V, Guarner C, Soriano G. Minimal Hepatic Encephalopathy Is Associated With Falls. American Journal of Gastroenterology 2011;106:476-82. [DOI: 10.1038/ajg.2010.413] [Cited by in Crossref: 120] [Cited by in F6Publishing: 111] [Article Influence: 10.9] [Reference Citation Analysis]
145 Labenz C, Toenges G, Schattenberg JM, Nagel M, Sprinzl MF, Nguyen-Tat M, Zimmermann T, Huber Y, Marquardt JU, Galle PR, Wörns MA. Clinical Predictors for Poor Quality of Life in Patients With Covert Hepatic Encephalopathy. J Clin Gastroenterol 2019;53:e303-7. [PMID: 30439761 DOI: 10.1097/MCG.0000000000001149] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
146 Srivastava A, Yadav SK, Lal R, Yachha SK, Thomas MA, Saraswat VA, Gupta RK. Effect of Surgical Portosystemic Shunt on Prevalence of Minimal Hepatic Encephalopathy in Children With Extrahepatic Portal Venous Obstruction: Assessment by Magnetic Resonance Imaging and Psychometry. Journal of Pediatric Gastroenterology & Nutrition 2010;51:766-72. [DOI: 10.1097/mpg.0b013e3181ecaf62] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
147 Bémeur C, Cudalbu C, Dam G, Thrane AS, Cooper AJL, Rose CF. Brain edema: a valid endpoint for measuring hepatic encephalopathy? Metab Brain Dis 2016;31:1249-58. [DOI: 10.1007/s11011-016-9843-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
148 Bejm K, Wojtkiewicz S, Sawosz P, Perdziak M, Pastuszak Z, Sudakou A, Guchek P, Liebert A. Influence of contrast-reversing frequency on the amplitude and spatial distribution of visual cortex hemodynamic responses. Biomed Opt Express 2019;10:6296-312. [PMID: 31853401 DOI: 10.1364/BOE.10.006296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
149 Quero Guillén JC, Herrerías Gutiérrez JM. Diagnostic methods in hepatic encephalopathy. Clin Chim Acta 2006;365:1-8. [PMID: 16168979 DOI: 10.1016/j.cca.2005.08.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
150 Montagnese S, Gordon HM, Jackson C, Smith J, Tognella P, Jethwa N, Sherratt RM, Morgan MY. Disruption of smooth pursuit eye movements in cirrhosis: Relationship to hepatic encephalopathy and its treatment. Hepatology 2005;42:772-81. [DOI: 10.1002/hep.20855] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
151 Flamm SL. Covert Hepatic Encephalopathy: Who Should Be Tested and Treated? Clin Liver Dis 2015;19:473-85. [PMID: 26195202 DOI: 10.1016/j.cld.2015.04.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
152 Singhal A, Nagarajan R, Hinkin CH, Kumar R, Sayre J, Elderkin-Thompson V, Huda A, Gupta RK, Han SH, Thomas MA. Two-dimensional MR spectroscopy of minimal hepatic encephalopathy and neuropsychological correlates in vivo. J Magn Reson Imaging 2010;32:35-43. [PMID: 20578008 DOI: 10.1002/jmri.22216] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
153 Kahlbrock N, Butz M, May ES, Brenner M, Kircheis G, Häussinger D, Schnitzler A. Lowered frequency and impaired modulation of gamma band oscillations in a bimodal attention task are associated with reduced critical flicker frequency. NeuroImage 2012;61:216-27. [DOI: 10.1016/j.neuroimage.2012.02.063] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
154 Zamora Nava LE, Delgadillo AT. Minimal hepatic encephalopathy. Annals of Hepatology 2011;10:S50-4. [DOI: 10.1016/s1665-2681(19)31607-2] [Cited by in Crossref: 8] [Article Influence: 0.7] [Reference Citation Analysis]
155 Michitaka K, Tokumoto Y, Uesugi K, Kisaka Y, Hirooka M, Konishi I, Mashiba T, Abe M, Hiasa Y, Matsuura B, Horiike N, Shoda T, Onji M. Neuropsychiatric dysfunction in patients with chronic hepatitis and liver cirrhosis. Hepatology Research 2008;38:1069-75. [DOI: 10.1111/j.1872-034x.2008.00374.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
156 Lauridsen MM, Grønbæk H, Næser EB, Leth ST, Vilstrup H. Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis. Metab Brain Dis 2012;27:559-65. [DOI: 10.1007/s11011-012-9318-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
157 Thomsen KL, Macnaughtan J, Tritto G, Mookerjee RP, Jalan R. Clinical and Pathophysiological Characteristics of Cirrhotic Patients with Grade 1 and Minimal Hepatic Encephalopathy. PLoS One. 2016;11:e0146076. [PMID: 26745876 DOI: 10.1371/journal.pone.0146076] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
158 Garcia-tsao G. Portal hypertension: . Current Opinion in Gastroenterology 2003;19:250-8. [DOI: 10.1097/00001574-200305000-00008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
159 Patidar KR, Bajaj JS. Covert and Overt Hepatic Encephalopathy: Diagnosis and Management. Clin Gastroenterol Hepatol 2015;13:2048-61. [PMID: 26164219 DOI: 10.1016/j.cgh.2015.06.039] [Cited by in Crossref: 87] [Cited by in F6Publishing: 65] [Article Influence: 12.4] [Reference Citation Analysis]
160 Butterworth RF. Hepatic encephalopathy in alcoholic cirrhosis. Handb Clin Neurol 2014;125:589-602. [PMID: 25307598 DOI: 10.1016/B978-0-444-62619-6.00034-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 3.2] [Reference Citation Analysis]
161 Brenner M, Butz M, May ES, Kahlbrock N, Kircheis G, Häussinger D, Schnitzler A. Patients with manifest hepatic encephalopathy can reveal impaired thermal perception. Acta Neurol Scand 2015;132:156-63. [DOI: 10.1111/ane.12376] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
162 Nardone R, De Blasi P, Höller Y, Brigo F, Golaszewski S, Frey VN, Orioli A, Trinka E. Intracortical inhibitory and excitatory circuits in subjects with minimal hepatic encephalopathy: a TMS study. Metab Brain Dis 2016;31:1065-70. [DOI: 10.1007/s11011-016-9848-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
163 Gupta T, Rathi S, K Dhiman R. Managing Encephalopathy in the Outpatient Setting. Euroasian J Hepatogastroenterol 2017;7:48-54. [PMID: 29201772 DOI: 10.5005/jp-journals-10018-1211] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
164 Krismer F, Roos JC, Schranz M, Graziadei IW, Mechtcheriakov S, Vogel W, Carpenter RH, Zoller H. Saccadic latency in hepatic encephalopathy: a pilot study. Metab Brain Dis 2010;25:285-95. [PMID: 20852922 DOI: 10.1007/s11011-010-9210-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
165 Hassan SS, Baumgarten TJ, Ali AM, Füllenbach N, Jördens MS, Häussinger D, Butz M, Schnitzler A, Groiss SJ. Cerebellar inhibition in hepatic encephalopathy. Clinical Neurophysiology 2019;130:886-92. [DOI: 10.1016/j.clinph.2019.02.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
166 Wuensch T, Ruether DF, Zöllner C, Mueller T, Jung T, Kaffarnik M, Kassner U, Schott E, Kiefer S, Pratschke J, Stockmann M, Jara M. Performance characterization of a novel electronic number connection test to detect minimal hepatic encephalopathy in cirrhotic patients. Eur J Gastroenterol Hepatol 2017;29:456-63. [PMID: 28092641 DOI: 10.1097/MEG.0000000000000806] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
167 Rössle M, Euringer W. Hepatic Encephalopathy in Patients with Transjugular Intrahepatic Portosystemic Shunt (TIPS). In: Mullen KD, Prakash RK, editors. Hepatic Encephalopathy. Totowa: Humana Press; 2012. pp. 211-20. [DOI: 10.1007/978-1-61779-836-8_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
168 Maharshi S, Sharma BC, Sachdeva S, Srivastava S, Sharma P. Efficacy of Nutritional Therapy for Patients With Cirrhosis and Minimal Hepatic Encephalopathy in a Randomized Trial. Clin Gastroenterol Hepatol 2016; 14: 454-460. quiz e33. [PMID: 26453952 DOI: 10.1016/j.cgh.2015.09.028] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
169 Esmat S, Garem NE, Raslan H, Elfekki M, Sleem GA. Critical flicker frequency is diagnostic of minimal hepatic encephalopathy. J Investig Med 2017;65:1131-5. [PMID: 28743700 DOI: 10.1136/jim-2017-000428] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
170 Torlot FJ, McPhail MJ, Taylor-Robinson SD. Meta-analysis: The diagnostic accuracy of critical flicker frequency in minimal hepatic encephalopathy. Aliment Pharmacol Ther. 2013;37:527-536. [PMID: 23293917 DOI: 10.1111/apt.12199] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 6.1] [Reference Citation Analysis]
171 Philonenko S, Rivière P, Mallet M, Poullenot F, Tripon S, Munteanu M, Boukherrouf R, Sultanik P, Roupret M, Thabut D, Rudler M. Neurocognitive impairment is associated with erectile dysfunction in cirrhotic patients. Digestive and Liver Disease 2019;51:850-5. [DOI: 10.1016/j.dld.2019.03.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
172 Baker L, Lanz B, Andreola F, Ampuero J, Wijeyesekera A, Holmes E, Deutz N. New technologies - new insights into the pathogenesis of hepatic encephalopathy. Metab Brain Dis 2016;31:1259-67. [PMID: 27696270 DOI: 10.1007/s11011-016-9906-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
173 Kircheis G, Hilger N, Häussinger D. Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy. Gastroenterology 2014;146:961-9. [PMID: 24365582 DOI: 10.1053/j.gastro.2013.12.026] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 5.7] [Reference Citation Analysis]
174 Amodio P, Ridola L, Schiff S, Montagnese S, Pasquale C, Nardelli S, Pentassuglio I, Trezza M, Marzano C, Flaiban C, Angeli P, Cona G, Bisiacchi P, Gatta A, Riggio O. Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology. 2010;139:510-518, 518.e1-518.e2. [PMID: 20470775 DOI: 10.1053/j.gastro.2010.04.057] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 5.3] [Reference Citation Analysis]
175 Liu A, Perumpail RB, Kumari R, Younossi ZM, Wong RJ, Ahmed A. Advances in cirrhosis: Optimizing the management of hepatic encephalopathy. World J Hepatol 2015; 7(29): 2871-2879 [PMID: 26692331 DOI: 10.4254/wjh.v7.i29.2871] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
176 Cordoba J. Hepatic Encephalopathy: From the Pathogenesis to the New Treatments. ISRN Hepatol 2014;2014:236268. [PMID: 27335836 DOI: 10.1155/2014/236268] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
177 Kruczek C, Görg B, Keitel V, Bidmon HJ, Schliess F, Häussinger D. Ammonia increases nitric oxide, free Zn(2+), and metallothionein mRNA expression in cultured rat astrocytes. Biol Chem 2011;392:1155-65. [PMID: 22050230 DOI: 10.1515/BC.2011.199] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
178 Labenz C, Toenges G, Schattenberg JM, Nagel M, Huber Y, Marquardt JU, Galle PR, Wörns MA. Health-related quality of life in patients with compensated and decompensated liver cirrhosis. Eur J Intern Med 2019;70:54-9. [PMID: 31530418 DOI: 10.1016/j.ejim.2019.09.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
179 Metwally MA, Biomy HA, Omar MZ, Sakr AI. Critical flickering frequency test: a diagnostic tool for minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2019;31:1030-1034. [PMID: 31274595 DOI: 10.1097/meg.0000000000001375] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
180 Mardini H, Saxby BK, Record CO. Computerized psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant. Gastroenterology. 2008;135:1582-1590. [PMID: 18647604 DOI: 10.1053/j.gastro.2008.06.043] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
181 Kubitz R, Keitel V, Scheuring S, Köhrer K, Häussinger D. Benign recurrent intrahepatic cholestasis associated with mutations of the bile salt export pump. J Clin Gastroenterol. 2006;40:171-175. [PMID: 16394881 DOI: 10.1097/01.mcg.0000196406.15110.60] [Cited by in Crossref: 59] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
182 Golaszewski S, Langthaler PB, Schwenker K, Florea C, Christova M, Brigo F, Trinka E, Nardone R. Abnormal cortical synaptic plasticity in minimal hepatic encephalopathy. Brain Research Bulletin 2016;125:200-4. [DOI: 10.1016/j.brainresbull.2016.07.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
183 Wunsch E, Koziarska D, Kotarska K, Nowacki P, Milkiewicz P. Normalization of the psychometric hepatic encephalopathy score in Polish population. A prospective, quantified electroencephalography study. Liver Int 2013;33:1332-40. [DOI: 10.1111/liv.12194] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
184 Sergeeva OA. GABAergic transmission in hepatic encephalopathy. Arch Biochem Biophys. 2013;536:122-130. [PMID: 23624382 DOI: 10.1016/j.abb.2013.04.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
185 Weissenborn K. Diagnosis of minimal hepatic encephalopathy. J Clin Exp Hepatol 2015;5:S54-9. [PMID: 26041959 DOI: 10.1016/j.jceh.2014.06.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
186 Shah NJ, Neeb H, Kircheis G, Häussinger D, Zilles K. Quantitative T1 and water content mapping in hepatic encephalopathy. In: Häussinger D, Kircheis G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. Dordrecht: Springer Netherlands; 2006. pp. 273-83. [DOI: 10.1007/1-4020-4456-9_19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
187 Sharma P, Kumar A. Minimal hepatic encephalopathy in patients with cirrhosis by measuring liver stiffness and hepatic venous pressure gradient. Saudi J Gastroenterol 2012;18:316-21. [PMID: 23006459 DOI: 10.4103/1319-3767.101126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
188 Jiménez B, Montoliu C, MacIntyre DA, Serra MA, Wassel A, Jover M, Romero-Gomez M, Rodrigo JM, Pineda-Lucena A, Felipo V. Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance. J Proteome Res. 2010;9:5180-5187. [PMID: 20690770 DOI: 10.1021/pr100486e] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
189 Lauridsen MM, Jepsen P, Vilstrup H. Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease. Metab Brain Dis. 2011;26:135-139. [PMID: 21484318 DOI: 10.1007/s11011-011-9242-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
190 Córdoba J. New assessment of hepatic encephalopathy. J Hepatol. 2011;54:1030-1040. [PMID: 21145874 DOI: 10.1016/j.jhep.2010.11.015] [Cited by in Crossref: 143] [Cited by in F6Publishing: 120] [Article Influence: 11.9] [Reference Citation Analysis]
191 Butz M, Timmermann L, Gross J, Pollok B, Südmeyer M, Kircheis G, Häussinger D, Schnitzler A. Cortical activation associated with asterixis in manifest hepatic encephalopathy. Acta Neurol Scand 2014;130:260-7. [DOI: 10.1111/ane.12217] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
192 Kircheis G, Bode JG, Hilger N, Kramer T, Schnitzler A, Häussinger D. Diagnostic and prognostic values of critical flicker frequency determination as new diagnostic tool for objective HE evaluation in patients undergoing TIPS implantation. Eur J Gastroenterol Hepatol. 2009;21:1383-1394. [PMID: 19738480 DOI: 10.1097/MEG.0b013e328310e0c3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
193 Häussinger D, Butz M, Schnitzler A, Görg B. Pathomechanisms in hepatic encephalopathy. Biol Chem 2021;402:1087-102. [PMID: 34049427 DOI: 10.1515/hsz-2021-0168] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
194 Sharma K, Pant S, Misra S, Dwivedi M, Misra A, Narang S, Tewari R, Bhadoria AS. Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: a randomized controlled trial. Saudi J Gastroenterol. 2014;20:225-232. [PMID: 25038208 DOI: 10.4103/1319-3767.136975] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
195 Montagnese S, De Rui M, Angeli P, Amodio P. Neuropsychiatric performance in patients with cirrhosis: Who is "normal"? J Hepatol 2017;66:825-35. [PMID: 27923694 DOI: 10.1016/j.jhep.2016.11.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
196 Stawicka A, Świderska M, Zbrzeźniak J, Sołowianowicz N, Woszczenko A, Flisiak R, Jaroszewicz J. Brain-derived neurotrophic factor as a potential diagnostic marker in minimal hepatic encephalopathy. Clin Exp Hepatol 2021;7:117-24. [PMID: 34027124 DOI: 10.5114/ceh.2021.103242] [Reference Citation Analysis]
197 Kircheis G, Görtelmeyer R, Fleig WE, Häussinger D. Critical assessment of the PHES test battery in patients with low-grade hepatic encephalopathy. In: Häussinger D, Kircheis G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. Dordrecht: Springer Netherlands; 2006. pp. 495-502. [DOI: 10.1007/1-4020-4456-9_39] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
198 Yang HY, Chen DH, Gong HT, Zheng PY. Advances in diagnosis and treatment of minimal hepatic encephalopathy. Shijie Huaren Xiaohua Zazhi 2012; 20(22): 2058-2062 [DOI: 10.11569/wcjd.v20.i22.2058] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
199 Sharma P, Sharma BC, Agrawal A, Sarin SK. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose. J Gastroenterol Hepatol. 2012;27:1329-1335. [PMID: 22606978 DOI: 10.1111/j.1440-1746.2012.07186.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 7.5] [Reference Citation Analysis]
200 Albrecht J. Cyclic GMP in blood and minimal hepatic encephalopathy: fine-tuning of the diagnosis. J Mol Med (Berl) 2007;85:203-5. [PMID: 17273819 DOI: 10.1007/s00109-007-0160-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
201 Ampuero J, Simón M, Montoliú C, Jover R, Serra MÁ, Córdoba J, Romero-Gómez M. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis. Gastroenterology 2015;149:1483-9. [PMID: 26299413 DOI: 10.1053/j.gastro.2015.07.067] [Cited by in Crossref: 74] [Cited by in F6Publishing: 60] [Article Influence: 10.6] [Reference Citation Analysis]
202 Mapelli D, Iannizzi P, Biancardi A, Schiff S, Del Piccolo F, Valenti P, Amodio P. Neuropsychological dysfunction in minimal hepatic encephalopathy: a review compared with own experience. In: Häussinger D, Kircheis G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. Dordrecht: Springer Netherlands; 2006. pp. 467-73. [DOI: 10.1007/1-4020-4456-9_36] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
203 Dhiman RK, Saraswat VA, Sharma BK, Sarin SK, Chawla YK, Butterworth R, Duseja A, Aggarwal R, Amarapurkar D, Sharma P, Madan K, Shah S, Seth AK, Gupta RK, Koshy A, Rai RR, Dilawari JB, Mishra SP, Acharya SK. Minimal hepatic encephalopathy: Consensus statement of a working party of the Indian National Association for Study of the Liver: Minimal hepatic encephalopathy. Journal of Gastroenterology and Hepatology 2010;25:1029-41. [DOI: 10.1111/j.1440-1746.2010.06318.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 6.7] [Reference Citation Analysis]
204 Götz T, Huonker R, Kranczioch C, Reuken P, Witte OW, Günther A, Debener S. Impaired evoked and resting-state brain oscillations in patients with liver cirrhosis as revealed by magnetoencephalography. Neuroimage Clin 2013;2:873-82. [PMID: 24179838 DOI: 10.1016/j.nicl.2013.06.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
205 Rudler M, Weiss N, Bouzbib C, Thabut D. Diagnosis and Management of Hepatic Encephalopathy. Clin Liver Dis 2021;25:393-417. [PMID: 33838857 DOI: 10.1016/j.cld.2021.01.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
206 Luo M, Ma P, Li L, Cao WK. Advances in psychometric tests for screening minimal hepatic encephalopathy: From paper-and-pencil to computer-aided assessment. Turk J Gastroenterol 2019;30:398-407. [PMID: 31060994 DOI: 10.5152/tjg.2019.18226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
207 Gazda J, Drotar P, Drazilova S, Gazda J, Gazda M, Janicko M, Jarcuska P. Artificial Intelligence and Its Application to Minimal Hepatic Encephalopathy Diagnosis. J Pers Med 2021;11:1090. [PMID: 34834442 DOI: 10.3390/jpm11111090] [Reference Citation Analysis]
208 Barone M, Suppressa P, Viggiani MT, Lenato GM, Scardapane A, Chiumarulo L, Ambrosini N, Leo AD, Sabbà C. Minimal portosystemic encephalopathy: A new nosological entity in patients with hereditary haemorrhagic telangiectasia. Eur J Intern Med 2021;90:43-8. [PMID: 34020869 DOI: 10.1016/j.ejim.2021.04.026] [Reference Citation Analysis]
209 Timmermann L, Butz M, Gross J, Ploner M, Südmeyer M, Kircheis G, Häussinger D, Schnitzler A. Impaired cerebral oscillatory processing in hepatic encephalopathy. Clin Neurophysiol 2008;119:265-72. [PMID: 18055256 DOI: 10.1016/j.clinph.2007.09.138] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
210 Ortiz M, Jacas C, Córdoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. Journal of Hepatology 2005;42:S45-53. [DOI: 10.1016/j.jhep.2004.11.028] [Cited by in Crossref: 178] [Cited by in F6Publishing: 166] [Article Influence: 10.5] [Reference Citation Analysis]
211 Weissenborn K. Psychometric tests for diagnosing minimal hepatic encephalopathy. Metab Brain Dis. 2013;28:227-229. [PMID: 22993201 DOI: 10.1007/s11011-012-9336-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
212 Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of Minimal Hepatic Encephalopathy. Metab Brain Dis 2004;19:253-67. [DOI: 10.1023/b:mebr.0000043975.01841.de] [Cited by in Crossref: 196] [Cited by in F6Publishing: 76] [Article Influence: 10.9] [Reference Citation Analysis]
213 Montagnese S, Amodio P, Morgan MY. Methods for Diagnosing Hepatic Encephalopathy in Patients with Cirrhosis: A Multidimensional Approach. Metab Brain Dis 2004;19:281-312. [DOI: 10.1023/b:mebr.0000043977.11113.2a] [Cited by in Crossref: 83] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
214 Nardone R, Taylor AC, Höller Y, Brigo F, Lochner P, Trinka E. Minimal hepatic encephalopathy: A review. Neurosci Res 2016;111:1-12. [PMID: 27153746 DOI: 10.1016/j.neures.2016.04.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
215 Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Urios A, Rodrigo JM, Felipo V. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J Clin Gastroenterol. 2009;43:272-279. [PMID: 18562979 DOI: 10.1097/mcg.0b013e31815e7f58] [Cited by in Crossref: 107] [Cited by in F6Publishing: 53] [Article Influence: 8.2] [Reference Citation Analysis]
216 Bajaj JS. Minimal hepatic encephalopathy matters in daily life. World J Gastroenterol 2008; 14(23): 3609-3615 [PMID: 18595126 DOI: 10.3748/wjg.14.3609] [Cited by in CrossRef: 98] [Cited by in F6Publishing: 87] [Article Influence: 7.0] [Reference Citation Analysis]
217 Bajaj JS, Cordoba J, Mullen KD, Amodio P, Shawcross DL, Butterworth RF, Morgan MY; International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN). Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther. 2011;33:739-747. [PMID: 21306407 DOI: 10.1111/j.1365-2036.2011.04590.x] [Cited by in Crossref: 216] [Cited by in F6Publishing: 182] [Article Influence: 19.6] [Reference Citation Analysis]
218 Zöllner HJ, Butz M, Jördens M, Füllenbach ND, Häussinger D, Schmitt B, Wittsack HJ, Schnitzler A. Chemical exchange saturation transfer imaging in hepatic encephalopathy. Neuroimage Clin 2019;22:101743. [PMID: 30856541 DOI: 10.1016/j.nicl.2019.101743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
219 Kircheis G, Knoche A, Hilger N, Manhart F, Schnitzler A, Schulze H, Häussinger D. Hepatic encephalopathy and fitness to drive. Gastroenterology 2009;137:1706-15.e1-9. [PMID: 19686744 DOI: 10.1053/j.gastro.2009.08.003] [Cited by in Crossref: 101] [Cited by in F6Publishing: 80] [Article Influence: 7.8] [Reference Citation Analysis]
220 Sharma P, Sharma BC, Puri V, Sarin SK. Minimal Hepatic Encephalopathy in Patients With Extrahepatic Portal Vein Obstruction. Am J Gastroenterology 2008;103:1406-12. [DOI: 10.1111/j.1572-0241.2008.01830.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
221 Groiss SJ, Butz M, Baumgarten TJ, Füllenbach N, Häussinger D, Schnitzler A. GABA-ergic tone hypothesis in hepatic encephalopathy – Revisited. Clinical Neurophysiology 2019;130:911-6. [DOI: 10.1016/j.clinph.2019.03.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
222 Amorós A, Aparicio JR, Garmendia M, Casellas JA, Martínez J, Jover R. Deep sedation with propofol does not precipitate hepatic encephalopathy during elective upper endoscopy. Gastrointest Endosc. 2009;70:262-268. [PMID: 19394004 DOI: 10.1016/j.gie.2008.10.038] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
223 Felipo V, Ordoño JF, Urios A, El Mlili N, Giménez-Garzó C, Aguado C, González-Lopez O, Giner-Duran R, Serra MA, Wassel A, Rodrigo JM, Salazar J, Montoliu C. Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests. Hepatology 2012;55:530-9. [PMID: 21953369 DOI: 10.1002/hep.24704] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 6.0] [Reference Citation Analysis]
224 May ES, Butz M, Kahlbrock N, Brenner M, Hoogenboom N, Kircheis G, Häussinger D, Schnitzler A. Hepatic encephalopathy is associated with slowed and delayed stimulus-associated somatosensory alpha activity. Clinical Neurophysiology 2014;125:2427-35. [DOI: 10.1016/j.clinph.2014.03.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
225 Romero-Gómez M. Pharmacotherapy of hepatic encephalopathy in cirrhosis. Expert Opin Pharmacother. 2010;11:1317-1327. [PMID: 20384539 DOI: 10.1517/14656561003724721] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
226 Montagnese S, Balistreri E, Schiff S, De Rui M, Angeli P, Zanus G, Cillo U, Bombonato G, Bolognesi M, Sacerdoti D, Gatta A, Merkel C, Amodio P. Covert hepatic encephalopathy: Agreement and predictive validity of different indices. World J Gastroenterol 2014; 20(42): 15756-15762 [PMID: 25400460 DOI: 10.3748/wjg.v20.i42.15756] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
227 Özbaş B, Keskin O, Hecker H, Karahan I, Özbaş C, Kalkan Ç, Kartal A, Önder FO, Öncü BK, Gençdal G, Akyildiz M, Günşar F, Idilman R, Weissenborn K, Özütemiz Ö, Yurdaydin C. Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery. Hepatol Int 2021. [PMID: 34085147 DOI: 10.1007/s12072-021-10207-5] [Reference Citation Analysis]
228 Tiberi O, Tognarelli JM, Cook NA, Crossey MM, Dhanjal NS, Taylor-Robinson SD. Diagnosing and treating hepatic encephalopathy. Br J Hosp Med (Lond) 2015;76:646, 648-52, 654. [PMID: 26551495 DOI: 10.12968/hmed.2015.76.11.646] [Reference Citation Analysis]
229 Weissenborn K. Portosystemic encephalopathy. Neurologic Aspects of Systemic Disease Part II. Elsevier; 2014. pp. 661-74. [DOI: 10.1016/b978-0-7020-4087-0.00045-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
230 Poordad FF. Review article: the burden of hepatic encephalopathy. Aliment Pharmacol Ther. 2007;25 Suppl 1:3-9. [PMID: 17295846 DOI: 10.1111/j.1746-6342.2006.03215.x] [Cited by in Crossref: 238] [Cited by in F6Publishing: 200] [Article Influence: 15.9] [Reference Citation Analysis]
231 Ferenci P. Hepatic encephalopathy. Gastroenterol Rep (Oxf). 2017;5:138-147. [PMID: 28533911 DOI: 10.1093/gastro/gox013] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 8.8] [Reference Citation Analysis]
232 Häussinger D. Fulminant liver failure. Transplantation Proceedings 2003;35:920-1. [DOI: 10.1016/s0041-1345(03)00164-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
233 Tryc AB, Weissenborn K. Correctness is mandatory in science: response to 'Correct determination of critical flicker frequency is mandatory when comparisons to other tests are made'. Gut 2014;63:702-3. [PMID: 23921889 DOI: 10.1136/gutjnl-2013-305582] [Reference Citation Analysis]
234 Soriano G, Román E, Córdoba J, Torrens M, Poca M, Torras X, Villanueva C, Gich IJ, Vargas V, Guarner C. Cognitive dysfunction in cirrhosis is associated with falls: a prospective study. Hepatology 2012;55:1922-30. [PMID: 22213000 DOI: 10.1002/hep.25554] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 6.8] [Reference Citation Analysis]
235 Weissenborn K. PHES: one label, different goods?! J Hepatol 2008;49:308-12. [PMID: 18644646 DOI: 10.1016/j.jhep.2008.06.023] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
236 Gundling F, Zelihic E, Seidl H, Haller B, Umgelter A, Schepp W, Dodt C. How to diagnose hepatic encephalopathy in the emergency department. Annals of Hepatology 2013;12:108-14. [DOI: 10.1016/s1665-2681(19)31392-4] [Cited by in Crossref: 25] [Article Influence: 2.8] [Reference Citation Analysis]
237 Randolph C, Hilsabeck R, Kato A, Kharbanda P, Li YY, Mapelli D, Ravdin LD, Romero-Gomez M, Stracciari A, Weissenborn K; International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN). Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int. 2009;29:629-635. [PMID: 19302444 DOI: 10.1111/j.1478-3231.2009.02009.x] [Cited by in Crossref: 150] [Cited by in F6Publishing: 123] [Article Influence: 11.5] [Reference Citation Analysis]
238 Duarte-Rojo A, Ruiz-Margáin A, Macias-Rodriguez RU, Cubero FJ, Estradas-Trujillo J, Muñoz-Fuentes RM, Torre A. Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy. World J Gastroenterol 2016; 22(17): 4397-4402 [PMID: 27158209 DOI: 10.3748/wjg.v22.i17.4397] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
239 Schmid M, Peck-Radosavljevic M, König F, Mittermaier C, Gangl A, Ferenci P. A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis. Liver Int. 2010;30:574-582. [PMID: 20456040 DOI: 10.1111/j.1478-3231.2010.02213.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
240 Oeltzschner G, Butz M, Wickrath F, Wittsack H, Schnitzler A. Covert hepatic encephalopathy: elevated total glutathione and absence of brain water content changes. Metab Brain Dis 2016;31:517-27. [DOI: 10.1007/s11011-015-9760-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
241 Prakash R, Mullen KD. Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol 2010;7:515-25. [DOI: 10.1038/nrgastro.2010.116] [Cited by in Crossref: 174] [Cited by in F6Publishing: 152] [Article Influence: 14.5] [Reference Citation Analysis]
242 Eisen-Enosh A, Farah N, Burgansky-Eliash Z, Maharshak I, Polat U, Mandel Y. A dichoptic presentation device and a method for measuring binocular temporal function in the visual system. Exp Eye Res 2020;201:108290. [PMID: 33022269 DOI: 10.1016/j.exer.2020.108290] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
243 Goel A, Yadav S, Saraswat V, Srivastava A, Thomas MA, Pandey CM, Rathore R, Gupta R. Cerebral oedema in minimal hepatic encephalopathy due to extrahepatic portal venous obstruction: Cerebral oedema in extrahepatic portal venous obstruction. Liver International 2010;30:1143-51. [DOI: 10.1111/j.1478-3231.2010.02289.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
244 Jesús Maldonado-garza H, Vázquez-elizondo G, Obed Gaytán-torres J, Ricardo Flores-rendón Á, Graciela Cárdenas-sandoval M, Javier Bosques-padilla F. Prevalence of minimal hepatic encephalopathy in cirrhotic patients. Annals of Hepatology 2011;10:S40-4. [DOI: 10.1016/s1665-2681(19)31605-9] [Cited by in Crossref: 19] [Article Influence: 1.7] [Reference Citation Analysis]